title: Sequential administration of OKT3 (anti-CD3) and interleukin-2 in two patients with chemoresistant hematological disease.
authors.forename: M
authors.initials: M
authors.lastname: Massaia
authors.forename: A
authors.initials: A
authors.lastname: Bianchi
authors.forename: S
authors.initials: S
authors.lastname: Peola
authors.forename: P
authors.initials: P
authors.lastname: Borrione
authors.forename: C
authors.initials: C
authors.lastname: Attisano
authors.forename: A
authors.initials: A
authors.lastname: Pileri
mesh_terms: D000328:Adult; D004334:Drug Administration Schedule; D004351:Drug Resistance; D004359:Drug Therapy, Combination; D005260:Female; D006402:Hematologic Diseases / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D007376:Interleukin-2 / Q000627:therapeutic use*; D016853:Muromonab-CD3 / Q000627:therapeutic use*
chemical_list: D007376:Interleukin-2; D016853:Muromonab-CD3